Navigation Links
GenoLogics Announces Bioinformatics Partnership with Illumina

al companies, academic institutions, clinical research organizations, and biotechnology companies. Our tools provide researchers around the world with the performance, throughput, cost effectiveness, and flexibility necessary to perform the billions of genetic tests needed to extract valuable medical information from advances in genomics and proteomics. We believe this information will enable researchers to correlate genetic variation and biological function, which will enhance drug discovery and clinical research, allow diseases to be detected earlier, and permit better choices of drugs for individual patients. For more information, please visit www.Illumina.com.

###

Contact info:

GenoLogics Life Sciences Software, Inc. Tanis MacSween Manager, Marketing Communications 250.483.7063 tanis.macsween@genologics.com

Maurissa Bornstein, Public Relations Manager Illumina, Inc. Ph: 858.332.5055 Email: mbornstein@illumina.com


'"/>




Page: 1 2 3

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
4. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
5. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
9. Protox Announces Positive Clinical Data from Prostate Cancer Study
10. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
11. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
Post Your Comments:
(Date:9/5/2008)...rom a Simple Blood Draw Have,the Potential to Serv...e of Indications,Usin... Currently Developing a Blood-Based ...JERSEY CITY, New Jersey, September 5,/PRNewswire-F... a leader in,the development of microRNA-based dia...
(Date:9/4/2008)...treatment of Acute Myeloid ...swire/ -- Celator Pharmaceuticals today,announced ... granted orphan,drug designation to CPX-351 (Cytar...atment of Acute Myeloid Leukemia (AML)., Celator ...hase 2,studies with CPX-351. The first Phase 2 stu...
(Date:9/4/2008)...R testing for the diagnostic ...ewswire/ -- The U.S. Food & Drug,Administration (F...Test,the first assay for quantitating Hepatitis B...e,s real-time PCR technology to quantify the amoun...octors may use viral load,testing results to estab...
(Date:9/4/2008)...ogists States UFE Meets Level,A Evidence for Clini...nal,Radiology Treatment Is Safe, Effective Option ...pt. 4 /PRNewswire-USNewswire/ -- The Society of,In... nearly 4,500 doctors,scientists and allied healt... through minimally invasive treatment intervention...
Breaking Medicine Technology:Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 2Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 3Rosetta Genomics Identifies Potential microRNA Biomarkers in Blood Serum 4Celator Pharmaceuticals Receives Orphan Drug Designation for Anticancer Agent CPX-351 2FDA Approves First Hepatitis B Viral Load Test 2FDA Approves First Hepatitis B Viral Load Test 3Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 2Society of Interventional Radiology Applauds Report's Uterine Fibroid Embolization Recommendations 3Beavers can help ease drought 2279 1Beavers can help ease drought 2279 2Music Therapy Improves Stroke Outcomes 12359 1Music Therapy Improves Stroke Outcomes 12359 2Grant to study if early BPA exposure leads to late prostate cancer 12355 1Grant to study if early BPA exposure leads to late prostate cancer 12355 2Standard test for blood sugar control not accurate in diabetic dialysis patients 12354 1Standard test for blood sugar control not accurate in diabetic dialysis patients 12354 2
...E)--Mar 12, 2007 - Ceragenix Pharmaceuticals,Inc.... on,infectious disease and dermatology, today anno...pound demonstrated virtually no biofilm,formation ...heters treated with Ceragenins,were soaked daily i...eated catheter. At day 21, the catheters were chal...
... March 12, 2007: Progen Industries Limited,(ASX: P...PI-88,Phase II liver cancer data has been accepted...an Association for the Study of the Liver,(EASL). ... liver,cancer trial at the American Association fo...In expectation of having final data fully analysed...
Other Medicine Technology:Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm,Formation in 21 Day Study 2Ceragenix Announces Ceragenins Virtually Prevent Catheter Biofilm,Formation in 21 Day Study 3PI-88 Data to be Presented at Key International Conferences 2PI-88 Data to be Presented at Key International Conferences 3
(Date:9/4/2008)...RNewswire/ -- A groundbreaking program,dealing wit... status of,men, their shorter life spans, unmet ge... take place Wednesday, September 17 at White Plain...ers of the Westchester,medical and psychiatric soc....D. and Lionel Tiger, Ph.D., Dr. Legatto, an inte...
(Date:9/4/2008)...ol study, the presence of measles virus RNA was no...bances than in children with only GI disturbances....related to MMR vaccine timing. Study findings are... on September 4 ( http://dx.plos.org/10.1371/jour...n of measles vaccines in 1963, three to four milli...
(Date:9/4/2008)...in and pancreatic tumors , , THURSDAY, S...ing discoveries involving genetic mutations of two...nd pancreatic cancer -- may lead to new treatments...dies represent the most complete genetic analysis ...enetic map of these deadly cancers," Kenneth Kinzl...
(Date:9/4/2008)... are Sold-Out and Sustainable Packaging ...pt. 4 /PRNewswire/ -- The latest innovations in ra...s, and sustainable,packaging will be on full displ...September 9, 10, 11 at the Jacob K. Javits Convent...urals Pavilions at the event are sold-out and,sust...
Breaking Medicine News(10 mins):Health News:Study firmly shows no connection between measles, mumps, rubella (MMR) vaccine and autism 2Health News:Study firmly shows no connection between measles, mumps, rubella (MMR) vaccine and autism 3Health News:Genetic Mutations Linked to Deadly Cancers 2Health News:Genetic Mutations Linked to Deadly Cancers 3Health News:Genetic Mutations Linked to Deadly Cancers 4Health News:HBA Exhibit Floor Offers Global Resources to the Beauty and Personal Care Industry 2Health News:HBA Exhibit Floor Offers Global Resources to the Beauty and Personal Care Industry 3
...an inquiry into four deaths allegedly due to power... circumstances leading to the deaths that occurred...ospital superintendent S.C. Tiwari told IANS. Ear...d denied the deaths were due to power cut, stating...
...lions of pounds that have gone into the NHS have b...ivitas here has been “little or no evidence of imp... worst in the developed world”. In addition it sa...creased in proportion to the vast sums ploughed in...
...Lusaka, Zambia, have explained that the programme ...rst two years.// The leaders made their report on...IDS Conference in Toronto. They explained that the... thought that it is simply not possible to provide...
...ing a pilot project in sterilisation of street dog...t their animal birth control (ABC) initiative acro...ions across Tamil Nadu and neighbouring states hav...t was successfully tried by the Chennai Corporatio...
Other Medicine News:Health News:The Aids Programme In Zambia Reported As A Success 2
Cruciate Retaining, Posterior Stabilized and Constrained Components.
...bilized knee has an advanced design which provides...surfacing and inset patellas. Precision machined c...fit with tibial articular surface and patella to r...rovide easy intraoperative change of sizes. Increa...
StelKast's Proven knee system is a long term, quality solution based on a clinically proven design. Available in both posterior stabilized and anatomically correct cruciate retaining configurations.
The Foundation Knee CR System was designed to replicate normal knee kinematics. The patello- femoral joint has a recessed, deepened and extended patella groove to minimize advancement of the patella,
Medicine Products: